KIMBERLY MARLAR: Open Payments
NPI 1356667455 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 34 payments from 13 companies in 2025. Trend: 2023 $369 · 2024 $783 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 7 | $225 |
| Boston Scientific Corporation | 5 | $191 |
| Electromed, Inc. | 4 | $165 |
| PFIZER INC. | 6 | $111 |
| Medtronic, Inc. | 3 | $76 |
| Amgen Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: SMARTVEST, VYNDAQEL, ONYX FRONTIER, OptiCross 6, Repatha, ENROUTE Transcarotid Stent, WATCHMAN FLX, LUX-Dx Insertable Cardiac Monitor.
Industry payments across MS — which companies pay providers there.
